ACTIVE

Cryptobiotix

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result1,8 M €+49,8 %over 1 year
Gross margin3,9 M €+56,4 %over 1 year
Equity3,7 M €+86,9 %over 1 year
Workforce15,8 ETP+68,1 %over 1 year

Identity

Source · BCE/KBO

Cryptobiotix is a Public limited company incorporated in 2021. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Gent. It employs on average 15,8 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0762.565.104
Incorporation
27/01/2021
Legal form
Public limited company
Registered office
Technologiepark-Zwijnaarde 82
9052 Gent · FlandreSee on map
Contributed capital
61 500,00 €
Latest accounts
31/12/2025
Average workforce
15,8 ETP
Joint committees (3)
  • 1000
  • 207
  • 2070
Contacts
2 public details availableLog in to view
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 5 filings

Trend over 5 financial years

20252024202320222021
Income statement
Gross margin3,9 M €2,5 M €1,6 M €883,7 k €317,4 k €
EBITDA2,5 M €1,6 M €952,1 k €710,2 k €274,3 k €
Operating result2,3 M €1,5 M €837,6 k €662,5 k €239,2 k €
Net result1,8 M €1,2 M €618,5 k €501,6 k €187,7 k €
Balance sheet
Equity3,7 M €2 M €1,2 M €593,1 k €201,5 k €
Total assets5,7 M €4,2 M €2,7 M €1,8 M €631,1 k €
Cash572,4 k €2,3 M €1,5 M €509,6 k €226,6 k €
Debts633 k €999,2 k €785 k €664,2 k €401,3 k €
Other
Workforce15,8 ETP9,4 ETP8,3 ETP2,6 ETP1,2 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

4 active

Active mandates

DirectorMandates in this companyPeriod
AB Initio Management1024.944.956Represented by Baudot Aurélien
Directorsince 01/07/2025
PVDA Biosciences1025.196.364Represented by Van den Abbeele Pieter
Directorsince 01/07/2025
Aurélien Baudot
Managing director27/01/2021 → 15/05/2027
Pieter Van den Abbeele
Managing director27/01/2021 → 15/05/2027

Other companies at this address

Technologiepark-Zwijnaarde 82 9052 Gent
CompanyCBE no.
Amalus Therapeutics● Bankrupt
0803.929.268
APCOR R&M● Active
0600.952.909
Ardoyen● Active
0875.102.821
AVROXA● Active
0687.774.936
Benebiose● Active
0784.521.548
BioNeering● Active
0807.194.309
CONTREL EUROPE● Active
0426.204.637
CRODEON TECHNOLOGIES● Active
0642.754.761
Gulliver Biomed● Active
0692.527.837
ImplicitMeasures.com● Bankrupt
0657.989.701
Inbiose● Active
0534.887.593
INCUBATIE- EN INNOVATIECENTRUM UNIVERSITEIT● Active
0440.054.752
INNOVATIVE PHARMACEUTICS● Active
0883.574.582
Inspect● Active
0645.950.417
INVIBES ADVERTISING● Active
0836.533.938
KYTOS● Active
0768.755.286
Lares Solutions● Active
1015.346.906
MAYAKU PHARMACEUTICAL DEVELOPMENT● Active
0755.350.975
Microbial Resource Management Health● Active
0742.910.132
Microbial Resource Management Technologies● Active
0667.765.816

Full financial information

Source · NBB
20252024202320222021
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202227/01/2021
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/2021
Length of the financial year12 months12 months12 months12 months12 months
Filing date30/06/202611/06/202527/05/202422/06/202319/04/2022
General meeting29/06/202612/05/202529/04/202430/03/202324/01/2022
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 5 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202529/06/202630/06/2026DutchPDF
Abridged model31/12/202412/05/202511/06/2025DutchPDF
Abridged model31/12/202329/04/202427/05/2024DutchPDF
Abridged model31/12/202230/03/202322/06/2023DutchPDF
Abridged model31/12/202124/01/202219/04/2022DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active

Active mandates

DirectorMandates in this companyPeriod
AB Initio Management1024.944.956Represented by Baudot Aurélien
Directorsince 01/07/2025
PVDA Biosciences1025.196.364Represented by Van den Abbeele Pieter
Directorsince 01/07/2025
Aurélien Baudot
Managing director27/01/2021 → 15/05/2027
Pieter Van den Abbeele
Managing director27/01/2021 → 15/05/2027

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates15/05/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other24/07/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates18/05/2021
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other29/01/2021
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings5 filings
Mandates
AB Initio Management
PVDA Biosciences
Aurélien Baudot
Pieter Van den Abbeele
202120222023202420252026
Cryptobiotix
Technologiepark-Zwijnaarde 82, 9052 Zwijnaarde
Director
Director
Managing director
Managing director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Technologiepark-Zwijnaarde 82, 9052 ZwijnaardeCurrent
accounts 2021 → 2025
Accounts 2025 · 2026-00244880

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
CryptobiotixCurrent
accounts 2021 → 2025
Accounts 2025 · 2026-00244880

Events

  1. 2025
    Annual accounts 20251,8 M €↑
  2. 2024
    Annual accounts 20241,2 M €↑
  3. 2023
    Annual accounts 2023618,5 k €↑
  4. 2022
    Annual accounts 2022501,6 k €↑
  5. 2021
    Annual accounts 2021187,7 k €
  6. 27/01/2021
    IncorporationPublic limited company